A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/7076 (2006.01) A61K 31/7068 (2006.01) A61K 31/7084 (2006.01) A61P 31/12 (2006.01)
Patent
CA 2743451
The disclosed invention is a composition for and a method of treating a Flaviviridae (including BVDB and HCV), Orthornyxoviridae (including Influenza A and B) or Paratnyxoviridae (including RSV) infection, or conditions related to abnormal cellular proliferation, in a host, including animals, and especially humans, using a nucleoside of general formula (I)-(XXIII) or its pharmaceutically acceptable salt or prodrug. This invention also provides an effective process to quantify the viral load, and in particular BVDV, HCV or West Nile Virus load, in a host, using real-time polymerase chain reaction ("TR-PCR'). Additionally, the invention discloses probe molecules that can fluoresce proportionally to the amount of virus present in a sample.
Stuyver Lieven
Watanabe Kyoichi A.
Mbm Intellectual Property Law Llp
Pharmasset Inc.
LandOfFree
Modified nucleosides for the treatment of viral infections... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified nucleosides for the treatment of viral infections..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified nucleosides for the treatment of viral infections... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1811176